Top in endocrinology: Long-term gestational diabetes risks; evolution of testosterone use
Click Here to Manage Email Alerts
A new study published in JAMA showed an increase in the incidence of gestational diabetes in the United States, from 47.6 per 1,000 live births to 63.5 per 1,000 live births between 2011 and 2019.
According to researchers, gestational diabetes is one of the leading common complications of pregnancy and is associated with an increased risk for type 2 diabetes in mothers and adverse neonatal outcomes and cardiometabolic risk later in life among children. A review of the study was the top story in endocrinology last week.
Another top story was on the increase in testosterone supplementation over the past 20 years. “Once patients are on testosterone, it’s very hard to get them off,” Ronald Tamler, MD, PhD, director of digital health implementation at Mount Sinai Health System and professor of medicine at the Icahn School of Medicine at Mount Sinai, told Healio.
Read these and more top stories in endocrinology below:
Gestational diabetes and some of its treatments pose long-term risks to mothers, children
Gestational diabetes is a leading common complication of pregnancy in the United States, affecting up to one in 20 women. Read more.
Focus on CV risk, T Trials follows 20-year rise in testosterone use
During the past 2 decades, Endocrine Today has reported on the latest developments in testosterone therapy, including new formulations, debates over indications, and trials assessing risks and benefits for older men. Read more.
Mortality risk higher with sleeve gastrectomy vs. gastric bypass for adults with diabetes
Adults in Finland and Sweden with diabetes who underwent sleeve gastrectomy were more likely to die from any cause compared with those who underwent gastric bypass, according to a study published in Diabetes Care. Read more.
FDA clears tubeless hybrid closed-loop insulin delivery system for young children
The FDA has cleared the first tubeless hybrid closed-loop insulin delivery system for use by children aged 2 to 5 years with type 1 diabetes, according to an industry press release. Read more.
Adherence to stroke prevention guidelines improving, but still suboptimal in diabetes
More adults with type 2 diabetes achieved guideline-recommended strategies for stroke prevention in 2018 compared with 2001, but further improvements are needed, according to study findings published in Diabetes Care. Read more.